AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 95 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,242,294 | -61.2% | 1,762,115 | -32.5% | 0.66% | -59.6% |
| Q2 2023 | $28,968,355 | +72147.5% | 2,612,115 | 0.0% | 1.62% | -38.5% |
| Q1 2023 | $40,096 | -34.6% | 2,612,115 | -5.4% | 2.64% | -35.6% |
| Q4 2022 | $61,291 | -99.8% | 2,762,115 | +37.3% | 4.10% | +78.5% |
| Q3 2022 | $32,858,000 | +12.4% | 2,012,115 | 0.0% | 2.30% | +3.9% |
| Q2 2022 | $29,236,000 | -21.3% | 2,012,115 | 0.0% | 2.21% | -22.5% |
| Q1 2022 | $37,164,000 | -22.3% | 2,012,115 | 0.0% | 2.85% | +0.3% |
| Q4 2021 | $47,828,000 | -10.2% | 2,012,115 | -6.9% | 2.84% | +31.5% |
| Q3 2021 | $53,253,000 | -3.3% | 2,162,115 | -3.0% | 2.16% | +15.7% |
| Q2 2021 | $55,070,000 | +2.5% | 2,228,667 | -9.6% | 1.87% | +56.2% |
| Q1 2021 | $53,752,000 | -14.5% | 2,464,545 | -0.0% | 1.20% | -20.0% |
| Q4 2020 | $62,895,000 | -9.6% | 2,464,547 | -2.0% | 1.50% | -44.0% |
| Q3 2020 | $69,538,000 | +2.6% | 2,514,546 | -0.0% | 2.67% | +3.4% |
| Q2 2020 | $67,804,000 | – | 2,514,547 | – | 2.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |